EAM
MEDP icon

Empirical Asset Management’s Medpace MEDP Stock Holding History

Empirical Asset Management’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$606K Sell
1,145
-31
-3% -$14.3K 0.14% 197
2026
Q1 		$565K Sell
1,176
-827
-41% -$423K 0.15% 197
2025
Q4 		$1.12M Sell
2,003
-186
-8% -$106K 0.32% 84
2025
Q3 		$1.13M Buy
2,189
+196
+10% +$85.6K 0.31% 80
2025
Q2 		$626K Buy
1,993
+459
+30% +$138K 0.19% 163
2025
Q1 		$467K Sell
1,534
-1,571
-51% -$528K 0.16% 201
2024
Q4 		$230K Buy
+3,105
New +$1.05M 0.08% 279

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Empirical Asset Management's MEDP Position: Q2 2026 in Review

Empirical Asset Management reduced its Medpace (MEDP) stake by 2.6% in Q2 2026, selling an estimated $14.3K and leaving 1,145 shares worth $606K. The position accounts for 0.14% of the portfolio, ranked #197.

Empirical Asset Management first reported a position in MEDP in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.13M in Q3 2025. 697 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Empirical Asset Management held 1,145 shares of Medpace worth $606K as of Q2 2026.
  • Empirical Asset Management sold 31 Medpace shares in Q2 2026, an estimated $14.3K.
  • Medpace made up 0.14% of Empirical Asset Management's portfolio in Q2 2026, its #197 holding.
  • Empirical Asset Management first reported a position in Medpace in Q4 2024 and has held it in 7 quarters since.
  • Empirical Asset Management's Medpace position peaked at $1.13M in Q3 2025.
  • 697 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Empirical Asset Management's 13F filing for Q2 2026, filed 10 Aug 2026.